View in EDS HTML Full Text PDF Full Text

A synthetic benzoxazine dimer derivative targets c-Myc to inhibit colorectal cancer progression.

Saved in:
Bibliographic Details
Title: A synthetic benzoxazine dimer derivative targets c-Myc to inhibit colorectal cancer progression.
Authors: Sriratanasak N; Faculty of Pharmaceutical Sciences, Department of Pharmacology and Physiology, Chulalongkorn University, Bangkok, Thailand.; Faculty of Pharmaceutical Sciences, Center of Excellence in Cancer Cell and Molecular Biology, Chulalongkorn University, Bangkok, Thailand.; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany., Nutho B; Faculty of Science, Department of Pharmacology, Mahidol University, Bangkok, Thailand., Wattanathana W; Faculty of Engineering, Department of Materials Engineering, Kasetsart University, Bangkok, Thailand., Phaonakrop N; Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand, 12120., Panasawatwong B; Faculty of Science, Department of Pharmacology, Mahidol University, Bangkok, Thailand., Erlenbach-Wuensch K; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany., Roytrakul S; Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand, 12120., Schneider-Stock R; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Germany.; Adjunct professor at Mahidol University, Bangkok, Thailand., Chanvorachote P; Faculty of Pharmaceutical Sciences, Department of Pharmacology and Physiology, Chulalongkorn University, Bangkok, Thailand.; Faculty of Pharmaceutical Sciences, Center of Excellence in Cancer Cell and Molecular Biology, Chulalongkorn University, Bangkok, Thailand.; Sustainable Environment Research Institute, Chulalongkorn University, Bangkok, Thailand.
Source: Molecular oncology [Mol Oncol] 2026 Mar; Vol. 20 (3), pp. 688-708. Date of Electronic Publication: 2025 Oct 14.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41088563
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A synthetic benzoxazine dimer derivative targets c-Myc to inhibit colorectal cancer progression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sriratanasak+N%22">Sriratanasak N</searchLink>; Faculty of Pharmaceutical Sciences, Department of Pharmacology and Physiology, Chulalongkorn University, Bangkok, Thailand.; Faculty of Pharmaceutical Sciences, Center of Excellence in Cancer Cell and Molecular Biology, Chulalongkorn University, Bangkok, Thailand.; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Nutho+B%22">Nutho B</searchLink>; Faculty of Science, Department of Pharmacology, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Wattanathana+W%22">Wattanathana W</searchLink>; Faculty of Engineering, Department of Materials Engineering, Kasetsart University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Phaonakrop+N%22">Phaonakrop N</searchLink>; Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand, 12120.<br /><searchLink fieldCode="AU" term="%22Panasawatwong+B%22">Panasawatwong B</searchLink>; Faculty of Science, Department of Pharmacology, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Erlenbach-Wuensch+K%22">Erlenbach-Wuensch K</searchLink>; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Roytrakul+S%22">Roytrakul S</searchLink>; Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand, 12120.<br /><searchLink fieldCode="AU" term="%22Schneider-Stock+R%22">Schneider-Stock R</searchLink>; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Germany.; Adjunct professor at Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Chanvorachote+P%22">Chanvorachote P</searchLink>; Faculty of Pharmaceutical Sciences, Department of Pharmacology and Physiology, Chulalongkorn University, Bangkok, Thailand.; Faculty of Pharmaceutical Sciences, Center of Excellence in Cancer Cell and Molecular Biology, Chulalongkorn University, Bangkok, Thailand.; Sustainable Environment Research Institute, Chulalongkorn University, Bangkok, Thailand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2026 Mar; Vol. 20 (3), pp. 688-708. <i>Date of Electronic Publication: </i>2025 Oct 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41088563
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.70127
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 688
    Titles:
      – TitleFull: A synthetic benzoxazine dimer derivative targets c-Myc to inhibit colorectal cancer progression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sriratanasak N
      – PersonEntity:
          Name:
            NameFull: Nutho B
      – PersonEntity:
          Name:
            NameFull: Wattanathana W
      – PersonEntity:
          Name:
            NameFull: Phaonakrop N
      – PersonEntity:
          Name:
            NameFull: Panasawatwong B
      – PersonEntity:
          Name:
            NameFull: Erlenbach-Wuensch K
      – PersonEntity:
          Name:
            NameFull: Roytrakul S
      – PersonEntity:
          Name:
            NameFull: Schneider-Stock R
      – PersonEntity:
          Name:
            NameFull: Chanvorachote P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1